CRBU
CRBU
NASDAQ · Biotechnology

Caribou Biosciences Inc

$1.57
+0.09 (+6.08%)
As of Feb 8, 2:08 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 52.03M 54.83M 47.58M
Net Income 8.35M 10.00M 7.87M
EPS
Profit Margin 16.0% 18.2% 16.6%
Rev Growth +22.7% -2.4% +14.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 50.68M 60.52M 50.56M
Total Equity 80.37M 94.36M 88.94M
D/E Ratio 0.63 0.64 0.57
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 16.78M 16.80M 15.25M
Free Cash Flow 8.41M 9.93M 9.62M